chemosensitivity

A chemosensitivity assay may help in choosing the best drug or drugs for the cancer being treated.

Measure chemosensitivity or endocrine sensitivity correlation with novel expression profiles.

This may obscure important differences in chemosensitivity among histologic subtypes of soft tissue sarcoma.

Arcuate nuclei are capable of chemosensitivity and have a proven role in controlling respiratory frequency.

A chemosensitivity assay is a laboratory test that measures the number of tumor cells that are killed by chemotherapy.

Results Enhancement of chemosensitivity in treated cells Cytotoxicity was expressed as the percentage growth inhibition compared with untreated control cells.

Correlate chemosensitivity (as defined by pCR) to TheraPrint Therapy Gene Assay results.

To determine the predictive power of chemosensitivity of the combination of MammaPrint and BluePrint as measured by pCR.

In MCF7/WT cells neither NOM nor other reversal compounds increased chemosensitivity to ADR (Table 2).

Mehta RS: Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.

This group of tumors, although less common than astrocytomas, has received increased attention in the past decade because of reports of chemosensitivity and a favorable survival rate when compared with astrocytomas of similar grade.

Human prostate cells with an introduced wild-type BRCA1 cDNA demonstrated a threefold to sixfold increase in chemosensitivity, as well as an increased susceptibility to drug-induced apoptosis [ 53].

The ability to rapidly generate many tumor cells from small biopsy specimens and frozen tissue provides significant opportunities for cell-based diagnostics and therapeutics (including chemosensitivity testing) and greatly expands the value of biobanking.

Measure chemosensitivity (as defined by pCR) or endocrine sensitivity (as defined by decrease in longest tumor diameter or RCB1) in the molecular subgroups as determined by combining MammaPrint and BluePrint results.